These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12437480)

  • 1. Murine pharmacogenomics: using the mouse to understand the genetics of drug therapy.
    Watters JW; McLeod HL
    Pharmacogenomics; 2002 Nov; 3(6):781-90. PubMed ID: 12437480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using genome-wide mapping in the mouse to identify genes that influence drug response.
    Watters JW; McLeod HL
    Trends Pharmacol Sci; 2003 Feb; 24(2):55-8. PubMed ID: 12559764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacogenomics genomics approaches to optimizing drug therapy].
    Shi J; Chen S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Apr; 19(2):156-8. PubMed ID: 11941596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reality of pharmacogenomics: optimizing therapeutic decision making.
    Lee CR; Zeldin DC
    Environ Health Perspect; 2003 Aug; 111(11):A566-7. PubMed ID: 12928152
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development.
    Lee W; Lockhart AC; Kim RB; Rothenberg ML
    Oncologist; 2005 Feb; 10(2):104-11. PubMed ID: 15709212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomic considerations in drug delivery.
    Attar M; Lee VH
    Pharmacogenomics; 2003 Jul; 4(4):443-61. PubMed ID: 12831323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics and drug response in cardiovascular disorders.
    Siest G; Jeannesson E; Berrahmoune H; Maumus S; Marteau JB; Mohr S; Visvikis S
    Pharmacogenomics; 2004 Oct; 5(7):779-802. PubMed ID: 15469403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically modified mouse models for pharmacogenomic research.
    Liggett SB
    Nat Rev Genet; 2004 Sep; 5(9):657-63. PubMed ID: 15372087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomic discovery approaches: will the real genes please stand up?
    Walgren RA; Meucci MA; McLeod HL
    J Clin Oncol; 2005 Oct; 23(29):7342-9. PubMed ID: 16145062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents.
    Meletiadis J; Chanock S; Walsh TJ
    Pharmacogenomics; 2008 May; 9(5):561-84. PubMed ID: 18466103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shifting emphasis from pharmacogenomics to theragnostics.
    Ozdemir V; Williams-Jones B; Glatt SJ; Tsuang MT; Lohr JB; Reist C
    Nat Biotechnol; 2006 Aug; 24(8):942-6. PubMed ID: 16900136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Special report: pharmacogenomics of cancer-candidate genes.
    Technol Eval Cent Assess Program Exec Summ; 2007 Nov; 22(5):1-3. PubMed ID: 18080403
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacogenomics: marshalling the human genome to individualise drug therapy.
    Evans WE
    Gut; 2003 May; 52 Suppl 2(Suppl 2):ii10-8. PubMed ID: 12651877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human genetic variation and personalized medicine.
    Agrawal S; Khan F
    Indian J Physiol Pharmacol; 2007; 51(1):7-28. PubMed ID: 17877289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension pharmacogenomics: current status and future directions.
    Johnson JA; Turner ST
    Curr Opin Mol Ther; 2005 Jun; 7(3):218-25. PubMed ID: 15977418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics in drug development.
    McCarthy AD; Kennedy JL; Middleton LT
    Philos Trans R Soc Lond B Biol Sci; 2005 Aug; 360(1460):1579-88. PubMed ID: 16096107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics and the concept of individualized medicine.
    Shastry BS
    Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetic screening for drug therapy: from single gene markers to decision making in the next generation sequencing era.
    Tzvetkov M; von Ahsen N
    Pathology; 2012 Feb; 44(2):166-80. PubMed ID: 22228255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations of pharmacogenomic predictor discovery in Phase II clinical trials.
    Pusztai L
    Pharmacogenomics; 2007 Oct; 8(10):1443-8. PubMed ID: 17979517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human pharmacogenomic variations and their implications for antifungal efficacy.
    Meletiadis J; Chanock S; Walsh TJ
    Clin Microbiol Rev; 2006 Oct; 19(4):763-87. PubMed ID: 17041143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.